Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort - Poll - MDSpire

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort

  • By

  • Vincenzo Mangialardi

  • Giuseppe Macchitella

  • Rita Vitobello

  • Antonella Teofilo

  • Nicola Cavalli

  • Caterina Lapucci

  • Marco Vercellino

  • Elisa Idini

  • Jessica Frau

  • Pietro Iaffaldano

  • Paola Cavalla

  • Matilde M. Inglese

  • Eleonora Cocco

  • Damiano Paolicelli

  • May 31, 2026

  • 0 min

Share

Original Source(s)

Real-World Effectiveness and Safety of Ofatumumab in Relapsing Multiple Sclerosis: Comparison of Treatment-Naïve Patients and Switchers in a Multicenter Cohort

  • by Vincenzo Mangialardi, Giuseppe Macchitella, Rita Vitobello, Antonella Teofilo, Nicola Cavalli, Caterina Lapucci, Marco Vercellino, Elisa Idini, Jessica Frau, Pietro Iaffaldano, Paola Cavalla, Matilde M. Inglese, Eleonora Cocco, Damiano Paolicelli

  • May 31, 2026

Related Content

Epitranscriptomic regulation by m6A in immunity and autoimmune disorders: emerging mechanisms and clinical perspectives

Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort